Published in J Am Acad Dermatol on June 01, 1995
The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg (2011) 2.16
Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol (2009) 1.16
Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer--a case report. Virchows Arch (2006) 1.15
Augmentation mammaplasty using implants: a review. Arch Plast Surg (2012) 0.98
Sézary syndrome in association with silicone breast implant. J Am Acad Dermatol (1995) 0.98
Anaplastic large cell lymphoma associated with breast implant: a case report. World J Plast Surg (2012) 0.94
Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders. Oncologist (2013) 0.81
Lymphocytoma cutis following excision arthroplasty. Indian J Dermatol (2011) 0.79
New B-cell Lymphomas in the Setting of a Previous Rare Breast Implant-Associated B-cell Lymphoma. Plast Reconstr Surg Glob Open (2016) 0.75
Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndrome. J Clin Oncol (2012) 0.75
A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer (2016) 0.75
Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations. Int J Womens Dermatol (2017) 0.75
The nucleotide sequence of the cloned rpoD gene for the RNA polymerase sigma subunit from E coli K12. Nucleic Acids Res (1981) 5.52
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet (2001) 4.96
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol (2001) 3.92
Lead poisoning among low-income children in Orange County, California. A need for regionally differentiated policy. JAMA (1993) 3.77
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Phase II/III randomized trial of TCH346 in patients with ALS. Neurology (2007) 3.22
Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest (1999) 2.58
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol (1992) 2.45
'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess (2008) 2.34
Mycosis fungoides palmaris et plantaris. Arch Dermatol (1995) 2.25
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut (2011) 2.14
Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet (2001) 2.11
Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. J Eur Acad Dermatol Venereol (2008) 2.11
Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia (2011) 2.06
Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess (2007) 2.06
A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. Int J Tuberc Lung Dis (2009) 2.02
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99
Animal companions and one-year survival of patients after discharge. Public Health Rep (1982) 1.93
The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res (1998) 1.88
Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst (1998) 1.81
Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nat Struct Biol (1997) 1.80
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol (2007) 1.80
A critical evaluation of HIPE data. Ir Med J (2012) 1.77
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75
Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol (1990) 1.72
Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol (1999) 1.71
Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol (1989) 1.65
RNA-dependent DNA polymerase activity in virus-like particles isolated from human milk. Nature (1971) 1.63
Location of an F-pilin pool in the inner membrane. J Bacteriol (1981) 1.58
Aorto-left renal vein fistula: is there a place for endovascular management? J Endovasc Surg (1999) 1.57
Dark matter search results from the CDMS II experiment. Science (2010) 1.57
The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technol Assess (2008) 1.57
A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1. Health Technol Assess (2006) 1.56
Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis (2005) 1.56
Characterization of skin-infiltrating lymphocytes in patients with psoriasis. J Invest Dermatol (1991) 1.55
The association of age and semen quality in healthy men. Hum Reprod (2003) 1.52
Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant. Cancer (1998) 1.52
The annual cost of psoriasis. J Am Acad Dermatol (1993) 1.51
The alteration of serum potassium level during sample transit. Practitioner (1989) 1.51
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51
Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent. Arch Intern Med (1990) 1.50
Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat Res (1995) 1.48
Incubation periods for paediatric AIDS patients. Nature (1988) 1.47
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer. J Clin Oncol (2000) 1.47
Autoimmune enteropathy with anti-goblet cell antibodies. Hum Pathol (1995) 1.47
Radiography of facial trauma, the lateral view is not required. Clin Radiol (1998) 1.46
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
Cerebral abscesses in a patient with AIDS caused by methicillin-resistant Staphylococcus aureus (MRSA) Int J STD AIDS (1997) 1.45
A randomized double-blind study of the effect of distant healing in a population with advanced AIDS. Report of a small scale study. West J Med (1998) 1.43
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation. Health Technol Assess (2011) 1.43
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study. Br J Dermatol (2012) 1.42
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. Health Technol Assess (2006) 1.42
Human papillomavirus typing in HIV-positive women. Infect Dis Obstet Gynecol (2001) 1.41
Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol (1992) 1.40
Chromosomes of human sperm: variability among normal individuals. Hum Genet (1985) 1.40
Two cases of near asphyxiation in children, using non-releasing plastic garden ties. Emerg Med J (2001) 1.39
Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol Microbiol (2001) 1.39
Requirements for training to ensure competence of endoscopists performing invasive procedures in children. J Pediatr Gastroenterol Nutr (1998) 1.38
The effect of tra mutations on the synthesis of the F-pilin membrane polypeptide. Mol Gen Genet (1981) 1.34
erbB-2 (HER-2) and breast cancer progression. Appl Immunohistochem Mol Morphol (2003) 1.33
Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol (2008) 1.32
A new activity in the Ftra operon which is required for F-pilin synthesis. Mol Gen Genet (1982) 1.32
Rapid human chromosome aberration analysis using fluorescence in situ hybridization. Int J Radiat Biol (1989) 1.28
Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy. Br J Surg (2000) 1.28
Changes in period mRNA levels in the brain and division of labor in honey bee colonies. Proc Natl Acad Sci U S A (2000) 1.28
Transmission of genetically diverse strains of HIV-1 in Pune, India. Indian J Med Res (1998) 1.26
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol (1996) 1.25
Influence of maternal education on child immunization and stunting in Kenya. Matern Child Health J (2011) 1.25
Analysis of transfer genes and gene products within the traB-traC region of the Escherichia coli fertility factor, F. J Bacteriol (1987) 1.23
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol (1992) 1.23
Infections complicating mycosis fungoides and Sézary syndrome. JAMA (1992) 1.23
Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci U S A (1991) 1.22
Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience. Pharmacoeconomics (1999) 1.21
Role of outer-membrane cytochromes MtrC and OmcA in the biomineralization of ferrihydrite by Shewanella oneidensis MR-1. Geobiology (2009) 1.21
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood (1999) 1.20
Trench-shaped binding sites promote multiple classes of interactions between collagen and the adherence receptors, alpha(1)beta(1) integrin and Staphylococcus aureus cna MSCRAMM. J Biol Chem (1999) 1.19
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother Pharmacol (2007) 1.19
Historic low Haemophilus influenzae type B case tally--Canada 2000. Can Commun Dis Rep (2001) 1.17
Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.17
Analysis of Escherichia coli K12 F factor transfer genes: traQ, trbA, and trbB. Plasmid (1987) 1.17
Structure of human factor D. A complement system protein at 2.0 A resolution. J Mol Biol (1994) 1.17
Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J Mol Biol (1998) 1.16
Eosinophilic gastroenteritis presenting in an adolescent with isolated colonic involvement. Gut (1986) 1.16
Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice. Clin Chem (1996) 1.15
Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res (1993) 1.14
Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst (1992) 1.14
Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.14
Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry (1994) 1.13
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 1.12
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol (2000) 1.12
Genes and gene products involved in the synthesis of F-pili. Basic Life Sci (1985) 1.12
Synthesis of F-pilin polypeptide in the absence of F traJ product. Plasmid (1984) 1.12
Phase I trial of Taxotere: five-day schedule. J Natl Cancer Inst (1992) 1.12
Spouses as observers of the events in their relationship. J Consult Clin Psychol (1981) 1.11
Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet (1997) 1.11
Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians. Br J Dermatol (2008) 1.10